The recommended UK price will rise by up to 170%, although the impact on consumers could be more limited.

Pharma group seeks to address US complaints about ‘foreign freeloaders’ who rely on Americans to pay more for medicines

Manufacturer Lilly has announced plans to hike the amount it charges private providers in the UK to bring it into line with 'other developed countries'.